Company
Mineralys Therapeutics Inc (NASDAQ:MLYS) Could Experience 62.37% Growth
In last trading session, Mineralys Therapeutics Inc (NASDAQ:MLYS) saw 0.51 million shares changing hands with its beta currently measuring 1.55. Company’s recent per share price
